BioPharm International is the longest running peer-reviewed publication serving professionals involved in developing and manufacturing biotech therapeutics. This global audience comprises of scientists, directors and executives in R&D, quality assurance/validation, process development, manufacturing, regulatory affairs and other professionals involved in critical functional units of biopharmaceutical organizations. Our electronic audience includes professionals who have requested more information, newsletters and the digital edition electronically from BioPharm International.
|
|